A Marilyn Leitch

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi request reprint Management of locoregional and systemic recurrence of breast cancer: to stage or not to stage and how
    A Marilyn Leitch
    Division of Surgical Oncology, UT Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 20:3194-8. 2013
  2. ncbi request reprint Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer
    A Marilyn Leitch
    Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9155, USA
    Am J Surg 190:539-42. 2005
  3. doi request reprint DNA methylation in benign breast epithelium in relation to age and breast cancer risk
    David M Euhus
    Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer Epidemiol Biomarkers Prev 17:1051-9. 2008
  4. doi request reprint Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer
    Armando E Giuliano
    Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California, USA
    JAMA 306:385-93. 2011
  5. ncbi request reprint Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk
    David M Euhus
    E6 222, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9155, USA
    Cancer Epidemiol Biomarkers Prev 16:1812-21. 2007
  6. doi request reprint Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a random
    Aman U Buzdar
    Office of Vice President for Clinical Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 14:1317-25. 2013
  7. pmc Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010
    Lee G Wilke
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Ann Surg Oncol 17:1989-94. 2010
  8. doi request reprint Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
    Judy C Boughey
    Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
    JAMA 310:1455-61. 2013
  9. doi request reprint Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011
    John A Olson
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 26:3530-5. 2008
  10. doi request reprint Volume of excision and cosmesis with routine cavity shave margins technique
    Julie Mook
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 19:886-91. 2012

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Management of locoregional and systemic recurrence of breast cancer: to stage or not to stage and how
    A Marilyn Leitch
    Division of Surgical Oncology, UT Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 20:3194-8. 2013
    ..However, when recurrent disease is suspected, it is appropriate to undertake re-staging to develop a rational management plan. The rationale and methods for appropriate surveillance and re-staging are discussed. ..
  2. ncbi request reprint Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer
    A Marilyn Leitch
    Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9155, USA
    Am J Surg 190:539-42. 2005
    ..This report elucidates factors influencing patient accrual...
  3. doi request reprint DNA methylation in benign breast epithelium in relation to age and breast cancer risk
    David M Euhus
    Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer Epidemiol Biomarkers Prev 17:1051-9. 2008
    ..In proliferative epithelium, such as breast, this may provide an individualized cell-based measure of cancer risk...
  4. doi request reprint Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer
    Armando E Giuliano
    Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California, USA
    JAMA 306:385-93. 2011
    ..Immunochemical staining of sentinel lymph nodes (SLNs) and bone marrow identifies breast cancer metastases not seen with routine pathological or clinical examination...
  5. ncbi request reprint Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk
    David M Euhus
    E6 222, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9155, USA
    Cancer Epidemiol Biomarkers Prev 16:1812-21. 2007
    ..It is not known whether TSG methylation or atypia in nipple duct lavage (NDL) samples is related to predicted breast cancer risk...
  6. doi request reprint Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a random
    Aman U Buzdar
    Office of Vice President for Clinical Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 14:1317-25. 2013
    ..We investigated the effect of the timing of trastuzumab administration with anthracycline and taxane neoadjuvant chemotherapy...
  7. pmc Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010
    Lee G Wilke
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Ann Surg Oncol 17:1989-94. 2010
    ..We proposed to study the degree of adherence with these measures among participating institutions in a multi-institutional trial...
  8. doi request reprint Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
    Judy C Boughey
    Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
    JAMA 310:1455-61. 2013
    ..The application of SLN surgery for staging the axilla following chemotherapy for women who initially had node-positive cN1 breast cancer is unclear because of high false-negative results reported in previous studies...
  9. doi request reprint Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011
    John A Olson
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 26:3530-5. 2008
    ..The impact of the timing of cALND on pathologic results and complications in these patients has not been examined...
  10. doi request reprint Volume of excision and cosmesis with routine cavity shave margins technique
    Julie Mook
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 19:886-91. 2012
    ..This study evaluates the volume of tissue removed in a group that underwent CSM versus one that underwent standard partial mastectomy (SPM) and explores cosmetic outcomes...
  11. ncbi request reprint Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer
    Masahiro Sakaguchi
    Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Ann Surg Oncol 10:117-25. 2003
    ....
  12. ncbi request reprint Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial
    Lee Gravatt Wilke
    Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
    Ann Surg Oncol 13:491-500. 2006
    ..Surgical complications associated with the sentinel lymph node biopsy surgical procedure are reported...
  13. pmc Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer
    Alison Unzeitig
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9155, USA
    Int J Surg Oncol 2012:725121. 2012
    ..009). Multivariate analysis revealed CSM, % DCIS, tumor size, and race to influence reexcisions. Conclusions. CSM is a technique that reduces reexcisions and mastectomy rates...
  14. ncbi request reprint False-positive sentinel lymph nodes in breast cancer patients caused by benign glandular inclusions: report of three cases and review of the literature
    Yan Peng
    Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9073, USA
    Am J Clin Pathol 130:21-7; quiz 146. 2008
    ....
  15. doi request reprint Aesthetic subunit of the breast: an analysis of women's preference and clinical implications
    Steven H Bailey
    Department of Plastic Surgery, University of Texas Southwestern Medical Center, 1801 Inwood Road, Dallas, TX 75390, USA
    Ann Plast Surg 68:240-5. 2012
    ..Patient outcomes following surgery can be enhanced by restoring volume and minimizing scars in this upper medial subunit of the breast...
  16. ncbi request reprint Validating the performance of the mammary sentinel lymph node team
    David M Euhus
    Division of Surgical Oncology, U T Southwestern Medical Center, Dallas, Texas 75390 9155, USA
    J Surg Oncol 79:209-15. 2002
    ..Standardized performance measures need to be established in order to optimize the transition to SLN biopsy only...
  17. doi request reprint Delays in time to treatment and survival impact in breast cancer
    Amy Brazda
    Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 17:291-6. 2010
    ..It remains controversial, however, whether a delay to treatment impacts survival. The purpose of this study was to evaluate whether delays from diagnosis to initial treatment in breast cancer impacts survival...
  18. ncbi request reprint Limitations of the Gail model in the specialized breast cancer risk assessment clinic
    David M Euhus
    The University of Texas Southwestern Center for Breast Care, Dallas, Texas 75390 9155, USA
    Breast J 8:23-7. 2002
    ....
  19. ncbi request reprint Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk
    David M Euhus
    Department of Pathology, University of Texas Southwestern Medical Center at Dallas, 75390 9155, USA
    J Natl Cancer Inst 94:858-60. 2002
    ..Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA...
  20. doi request reprint Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non-palpable breast lesions
    Rebecca L Klein
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Surg Oncol 105:591-4. 2012
    ..Objective was to determine if the marker could be utilized independently for lesion localization using intra-operative ultrasound alone...
  21. ncbi request reprint Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk
    Cheryl M Lewis
    Hamon Center for Therapeutic Oncology Research, Department of Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9155, USA
    Clin Cancer Res 11:166-72. 2005
    ..However, it is unclear whether promoter methylation of tumor suppressor genes in benign breast tissue is associated with an increased risk for breast cancer...
  22. ncbi request reprint Patient variables that predict atypical cytology by nipple duct lavage
    Zinaida I Bushnaq
    Department of Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Cancer 109:1247-54. 2007
    ..7% should consider undergoing lavage for any fluid-yielding ducts, but it is not known whether increased breast cancer risk or nipple fluid production predict lavage atypia...
  23. ncbi request reprint CASE 4. Fibrocystic breast disease in a 16-year-old female with PTEN hamartoma tumor syndrome
    Annette R Patterson
    Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Clin Oncol 24:525-7. 2006
  24. doi request reprint American College of Surgeons Oncology Group and the community surgeon
    David M Ota
    Department of Surgery, Duke University, 2400 Pratt Street, Terrace Level, Room 0311, Durham, NC 27705, USA
    Surg Oncol Clin N Am 20:439-45, vii. 2011
    ..Such trials are relevant to most practicing surgeons...
  25. ncbi request reprint Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011
    Anthony Lucci
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:3657-63. 2007
    ..The current study compares complications associated with SLN dissection (SLND) plus ALND, versus SLND alone...
  26. ncbi request reprint Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007
    Armando E Giuliano
    John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Ann Surg Oncol 14:2425-7. 2007